Management of 'difficult-to-treat' patients with chronic hepatitis C

被引:0
|
作者
Boccato, S
Alberti, A
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:190 / 198
页数:9
相关论文
共 50 条
  • [1] Treatment of hepatitis C in difficult-to-treat patients
    Peter Ferenci
    [J]. Nature Reviews Gastroenterology & Hepatology, 2015, 12 : 284 - 292
  • [2] Treatment of hepatitis C in difficult-to-treat patients
    Ferenci, Peter
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (05) : 284 - 292
  • [3] Treating hepatitis C in "difficult-to-treat" patients
    Pawlotsky, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 422 - 423
  • [4] Managing chronic hepatitis C in the difficult-to-treat patient
    Kemmer, Nyingi
    Neff, Guy W.
    [J]. LIVER INTERNATIONAL, 2007, 27 (10) : 1297 - 1310
  • [5] Optimizing dosage and duration therapy for chronic hepatitis C "difficult-to-treat patients"
    Ladero, Jose M.
    [J]. ANNALS OF HEPATOLOGY, 2008, 7 (04) : 392 - 394
  • [6] Novel drugs in the management of difficult-to-treat hepatitis C genotypes
    Cartwright, Emily J.
    Miller, Lesley
    [J]. HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2013, 5 : 53 - 61
  • [7] Tacrolimous in the Management of Difficult-to-Treat Autoimmune Hepatitis
    Hanouneh, Mohamad A.
    Garber, Ari
    Alsuleiman, Bayan
    Markus, Johnathon
    Barnes, David
    Carey, William
    McCullough, Arthur
    Lopez, Rocio
    Zein, Nizar N.
    Hanouneh, Ibrahim A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S882 - S882
  • [8] Management of difficult-to-treat inhibitor patients
    Giangrande, P. L. F.
    Escobar, M. A.
    [J]. HAEMOPHILIA, 2010, 16 : 52 - 57
  • [9] Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
    Pabjan, Pawel
    Brzdek, Michal
    Chrapek, Magdalena
    Dziedzic, Kacper
    Dobrowolska, Krystyna
    Paluch, Katarzyna
    Garbat, Anna
    Bloniarczyk, Piotr
    Reczko, Katarzyna
    Stepien, Piotr
    Zarebska-Michaluk, Dorota
    [J]. VIRUSES-BASEL, 2022, 14 (01):
  • [10] AGE AFFECTS ADHERENCE TO PEGINTERFERON-ALPHA AND RIBAVIRIN IN "DIFFICULT-TO-TREAT" PATIENTS WITH CHRONIC HEPATITIS C
    Lenci, I.
    Francioso, S.
    Carbone, M.
    De Leonardis, F.
    Baiocchi, L.
    Angelico, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113